Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Xue-Ji Chen"'
Autor:
Qiang Lin, Yue-E Liu, Xiao-Ying Xue, Xue-Ji Chen, Yu-Xia Ding, Chao-Xing Liu, Yue-Liang Qin, Wei-Qian Li, Xiao-Cang Ren
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Introduction Concurrent chemoradiotherapy with conventional fractionation has been acknowledged as one of the standard treatments for locally advanced non-small cell lung cancer (NSCLC). The radiotherapy dose of 60 Gy is far from enough for local tum
Externí odkaz:
https://doaj.org/article/d239939b02ca463b847a5c83a736c8c4
Autor:
Yue-E Liu, Xue-Ji Chen, Xiao-Cang Ren, Chao-Xing Liu, Qiang Lin, Jie Zong, Rui Zhang, Zhi-Jun Guo
Publikováno v:
World Journal of Gastrointestinal Oncology
Background The survival of patients treated with monotherapy for hepatic malignancies is not ideal. A comprehensive program of cryoablation combined with radiotherapy for the treatment of hepatic malignancies results in less trauma to the patients. I
Autor:
Xiao-Cang Ren, Xue-Ji Chen, Qiang Lin, Wei-Qian Li, Yu-Xia Ding, Chao-Xing Liu, Yue-E Liu, Rui Zhang, Yue-Liang Qin, Xiao-Ying Xue
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 10 (2020)
BMJ Open, Vol 10, Iss 10 (2020)
IntroductionConcurrent chemoradiotherapy with conventional fractionation has been acknowledged as one of the standard treatments for locally advanced non-small cell lung cancer (NSCLC). The radiotherapy dose of 60 Gy is far from enough for local tumo
Autor:
Zeng‑Li Feng, Dong-Ying Wang, Jie Zong, Xue‑Ji Chen, Qiang Lin, Hui‑Ling Su, Xiao‑Can Ren, Yu Peng, Yue‑E Liu, Xian Shu Gao
Publikováno v:
Oncology Letters
In this study, the maximum tolerated dose (MTD) of lobaplatin (LBP) when it was combined with docetaxel (TXT) for the treatment of solid tumours that had progressed following chemotherapy was determined, and toxicities to this regimen were evaluated.
Autor:
Xiao‑Can Ren, Shun‑Mao Ma, Xue‑Ji Chen, Hai‑Gang Wang, Zeng‑Li Feng, Feng‑Jie Meng, Qiang Lin, Yue‑E Liu, Zhen‑Yu Liu, Yu Peng, Liu‑Bin Chen
Publikováno v:
Oncology Letters
Gastric cancer is the fourth most common type of cancer globally and accounts for the second highest cancer-associated mortality rate in the world. Current treatment strategies for gastric cancer include surgery, radiotherapy, chemotherapy and target
Publikováno v:
Advanced Materials Research. 852:347-352
It mainly introduces a speed acquisition and prompt system based on STC89C52 in this paper.In the system,STC89C52 is used as the master chip to control the system and the speed is collected by the Hall sensor.The prompt system mainly consists of two
Autor:
Yuehua Huang, Yue-E Liu, Na Wang, Xue-Ji Chen, Xiao-Cang Ren, Qiang Lin, Xiaohui Ge, Yannan Zhao, Jun Ichi Asaumi, Jing Hu, Zhi-Jun Guo
Publikováno v:
Journal of Radiation Research
The Radiation Therapy Oncology Group reported a maximum tolerated dose of 74 Gy for patients with non-small cell lung cancer (NSCLC); however, it was unclear whether this dose could be safely administered to Asian patients due to differences in their
Autor:
Jing Hu, Xiao-Cang Ren, Na Wang, Chuilin Chang, Zhi-Jun Guo, Yue-E Liu, Qiang Lin, Jingmei Fu, Xue-Ji Chen, Yansheng Tian, Yannan Zhao
Publikováno v:
The Chinese-German Journal of Clinical Oncology. 11:6-10
Objective Capecitabine combined with docetaxel have demonstrated antitumor synergy for non-small cell lung cancer (NSCLC). Due to absence of phase I trial in China, we conducted this study to define the maximum-tolerated dose (MTD) of capecitabine wi
Autor:
Fan-Jie Meng, Xiao-Cang Ren, Yu Peng, Qiang Lin, Na Wang, Jie Zong, Yue-E Liu, Yan Chen, Bin Cao, Ya-Jun Ku, Xue-Ji Chen
Publikováno v:
Radiation Oncology (London, England)
Background Increasing the radiotherapy dose can result in improved local control for non-small-cell lung cancer (NSCLC) and can thereby improve survival. Accelerated hypofractionated radiotherapy can expose tumors to a high dose of radiation in a sho
Autor:
Xiao-Cang Ren, Quan-Yu Wang, Rui Zhang, Xue-Ji Chen, Na Wang, Yue-E Liu, Jie Zong, Zhi-Jun Guo, Dong-Ying Wang, Qiang Lin, Ren, Xiao-Cang, Wang, Quan-Yu, Zhang, Rui, Chen, Xue-Ji, Wang, Na, Liu, Yue-E, Zong, Jie, Guo, Zhi-Jun, Wang, Dong-Ying, Lin, Qiang
Publikováno v:
BMC Cancer; 4/23/2016, Vol. 16, p1-13, 13p, 8 Charts